Amicus prices Galafold at $315k per year

Amicus Therapeutics Inc. (NASDAQ:FOLD) said Monday that it will price Galafold migalastat at $315,000 per year and vowed to limit

Read the full 207 word article

How to gain access

Continue reading with a
two-week free trial.